Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks
US stocks were mostly lower as megacap tech and software slid, with Palantir down over 6% and Oracle down over 4%. Alphabet fell more than 5% after DeepMind VP Jumper left for Anthropic. Treasury yields rose; 10-year yield ended at 4.507%. Markets priced a 39% chance of a 25 bp Fed hike on July 28–29.
How this was made
The 30-second read
Why it matters
Most named tickers are included only because they moved on the day; only a subset has a concrete disclosed catalyst (e.g., APGE acquisition agreement, LGND convertible offering, SATS delayed interest payment, DFTX Phase 3 endpoint, and GOOGL executive departure).
Market read
Traders get a same-day risk-sentiment read-through from software/megacap tech weakness, plus a few actionable single-name catalysts (notably APGE, LGND, SATS, DFTX).
What to watch
No details are provided on valuation, guidance, or term structure beyond yield moves; without those, the macro read-through to each stock is uncertain.
Background
The piece is a broad market wrap citing rate-hike probabilities and then listing US movers across software, megacap tech, defense, chips, and several single-name catalysts.
Ticker impact
Palantir closed down more than 6% on Monday as software stocks weighed on the broader market.
Near-term downside bias consistent with sector weakness; no incremental PLTR-specific fundamental trigger cited.
Only the magnitude of the daily move is provided; the text does not disclose new PLTR fundamentals, guidance, or filings.
Oracle closed down more than 4% on Monday alongside weakness in software stocks.
Limited incremental signal beyond broader software drawdown; expect mean reversion only if sector stabilizes.
The article provides the daily performance but no new ORCL news (no earnings, guidance, deal, or regulatory item).
Intuit fell more than 3% on Monday as software stocks moved lower.
Short-term pressure likely tied to risk sentiment; direction depends on whether megacap tech weakness persists.
No company-specific information is disclosed beyond the intraday/close move.
Atlassian closed down more than 3% on Monday during broader software weakness.
Follow-through risk if software tape remains weak; otherwise could stabilize with the sector.
The text lacks any TEAM catalyst beyond the reported price move.
Autodesk closed down more than 3% on Monday as software stocks weighed on the market.
Near-term bias lower consistent with sector correlation; catalyst-free move reduces conviction.
Only the daily percentage move is cited; no ADSK-specific event is mentioned.
Workday closed down more than 3% on Monday amid weakness in software stocks.
Short-term downside/volatility likely tracks software sentiment; no standalone WDAY trigger.
The article provides performance but no new WDAY news (earnings, guidance, deal, or filings).
ServiceNow closed down more than 2% on Monday as software stocks moved lower.
Limited standalone signal; expect direction to follow megacap tech/software risk appetite.
The text does not include any NOW catalyst beyond the reported close.
Salesforce closed down more than 1% on Monday during the software-stock weakness.
Modest near-term pressure consistent with sector weakness; no new CRM-specific driver cited.
No new CRM fundamentals or events are described.
Market effects
Broad software and megacap tech weakness suggests traders are de-risking growth/tech beta amid rate-hike probability.
Overseas markets were higher, but US tech/software weakness dominated the tape.
Rate expectations (FOMC/ECB probabilities) are the macro driver framing cross-asset risk sentiment.
Counterpoint
The article’s biggest “news” is mostly correlated daily weakness; isolated catalysts (e.g., APGE deal, DFTX Phase 3) may be idiosyncratic and not imply sustained sector downtrend.
Key entities
- policy_makerFOMC
Markets are discounting a 39% chance of a +25 bp rate hike at the next meeting (July 28-29).
- policy_makerECB
Swaps discount a 10% chance of a +25 bp ECB rate hike at the next meeting (July 23).
- companyPalantir Technologies
Software stock that closed down more than 6% on Monday.
- companyAbbVie
Agreed to buy Apogee Therapeutics for $10.9 billion.
- companyLigand Pharmaceuticals
Announced intention to offer $550 million of convertible senior notes due 2031.
